Concordia Healthcare acquires legacy pharmaceutical products and acquires and develops orphan drugs.
Concordia is focused on acquiring Specialty Healthcare and Pharmaceutical Distribution companies.
Concordia trades on the NASDAQ Global Select Market® under the symbol CXRX, and on the Toronto Stock Exchange under the symbol CXR.
August 13, 2015
– Newly acquired Covis assets drive top line and EBITDA2 in the second quarter ...
August 12, 2015
August 12, 2015: Concordia Healthcare (NASDAQ: CXRX) (TSX: CXR) opens NASDAQ Concordia Healthcare ...